Biopharmaceutical Research Articles & Analysis
76 news found
Watertown, MA - June 29, 2025 - Biopharma PEG, a leading innovator in high-quality polyethylene glycol (PEG) derivatives, today announced it has successfully obtained Drug Master File (DMF) approval from the U.S. Food and Drug Administration (FDA) for its self-developed HZ-PEG-HZ (1K) product. The assigned DMF number is 041864. This significant achievement underscores Biopharma PEG's robust ...
Nanotechnology has unlocked groundbreaking advancements in drug delivery, disease diagnostics and laboratory technologies by synthesizing and manipulating substances at the nanoscale. However, industry and research laboratories face challenges in analyzing complex and diverse samples and require sensitive and reliable drug delivery systems to provide consistent results in support ...
"Our LncRNA Sequencing service empowers researchers to delve into this untapped regulatory landscape, paving the way for groundbreaking discoveries in diverse fields, from developmental biology to disease pathogenesis." ...
CD Formulation, a company in the field of biopharmaceutical studies, is revolutionizing the way impurity determination is conducted in the industry. ...
As a PDA member, Board Member, and PDA Chair, Jette’s dedication to PDA’s mission of advancing pharmaceutical/biopharmaceutical manufacturing science and regulation so members can better serve patients benefited not only PDA members but the entire industry. Created through the PDA Foundation for Pharmaceutical Education, Training, and Research, the ...
Alfa Chemistry's scientists collaborate with various research institutions and biopharmaceutical companies to advance the development of mRNA vaccines that have the potential to combat a wide range of infectious diseases. mRNA Vaccine Production Once a promising vaccine candidate is identified, Alfa Chemistry seamlessly transitions to the production phase. ...
Biopharma PEG, a leading name in the pharmaceutical industry, is proud to announce a groundbreaking advancement in the field of Antibody-Drug Conjugate (ADC) development. The company now offers monodispersed Polyethylene Glycols (PEGs) on a scale ranging from grams to kilograms, and even on a ton scale. Notable PEGs include mPEG36-NH2, NH2-PEG24-COOH, OH-PEG9-OH, mPEG8-SPA, and more.ADCs ...
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has launched a new line of Locust Bean Gum with advanced technical platforms to help scientists advance biopharmaceutical research. Over the past few decades, researchers have been working on developing delivery systems that can reduce side ...
Protein Metrics Inc., a leading provider of biopharmaceutical and proteomics analysis software, announced today a new partnership to advance glycoproteomics and biotherapeutics tools and research Macquarie University’s Analytical Glycoimmunology Group and Protein Metrics Inc. today have launched a strategic partnership scheme to further advance ...
Despite this apparent success, there are issues with biopharmaceutical antibody research and development – not least the cost of goods. ...
Polepharma, the network promoting excellence and innovation in the pharmaceutical and biopharmaceutical sectors, brings together research laboratories, production sites, contractors and training centers. ...
Mammoth Biosciences, a biotech company harnessing next-generation CRISPR technology to detect and cure disease, has been chosen by Endpoints News Editor John Carroll as one of the most promising biotech startups for this year’s Endpoints 11 annual special report. Comprising a team of scientist-founders, experienced biopharma veterans, and talented researchers, Mammoth is developing a ...
Building on its years of experience, Creative Proteomics Pronalyse announces the launch of its metabolite identification services of biopharmaceuticals for an accurate and efficient analysis of the metabolism for your biological drugs in vivo. ...
The CSPS Award of Leadership in Canadian Pharmaceutical Sciences is bestowed upon an individual who has demonstrated leadership in advancing the cause of pharmaceutical research and development in Canada. Prof. Dr. Loebenberg received a Bachelor of Science degree in Pharmacy from the Johannes Gutenberg-University, Mainz, Germany and a PhD in Pharmaceutics from the Johann Wolfgang ...
Cannabinoids and Radiation – Recent research from Columbia University shows that cannabinoids, a class of chemicals best known because of their presence in cannabis, may be able to enhance the effectiveness of radiotherapy. ...
The global opioids drug market is expected to reach US$ 31 billion by 2027, at a CAGR of 2.5% from the forecasted period of 2020-2027. Research reported in this publication was supported by the National Institute Of Neurological Disorders And Stroke (NINDS) of the National Institutes of Health (NIH) under Award Number R42NS120548. ...
Because enzymes have such a significant impact on human health, research on enzyme-based drugs has emerged as a focus in recent times. ...
” To find out more about Creative Proteomics’s biopharmaceutical solutions, please browse the complete portfolio on the website. ...
The publication centered on pre-clinical research for its proprietary, cannabinoid-derived analog KLS-13019 showing both the prevention and reversal of chemotherapy-induced peripheral neuropathy (CIPN). ...
(“Neuropathix” or the “Company”) (OTCQB:NPTX), a socially responsible pain management life sciences company, announced today that its CEO Dean Petkanas has issued a letter to its shareholders, providing commentary on the Company’s recently achieved milestones, updates on its research and financial positioning. Please see the contents of the letter ...